Resolution Therapeutics Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 55

Employees

  • Latest Deal Type
  • Series C
  • (Upcoming)

  • Investors
  • 3

Resolution Therapeutics General Information

Description

Developer of regenerative macrophage cell therapies designed to treat inflammatory organ diseases and support tissue repair. The company offers engineered autologous macrophage therapies that reduce inflammation, limit fibrosis and promote tissue regeneration, enabling patients with advanced organ diseases, including end-stage liver disease, to receive cell-based treatments.

Contact Information

Formerly Known As
Syncona Collaboration (E)
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 245 Hammersmith Road
  • London W6 8PW
  • England, United Kingdom
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 245 Hammersmith Road
  • London W6 8PW
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Resolution Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series C) 31-Jan-2027 Upcoming
4. Later Stage VC (Series B) 03-Oct-2024 Completed Clinical Trials - Phase 2
3. Early Stage VC (Series A) 02-Dec-2020 Completed Clinical Trials - Phase 2
2. Seed Round 04-May-2018 Completed Clinical Trials - Phase 2
1. University Spin-Out 01-Jan-2017 Completed Clinical Trials - Phase 2
To view Resolution Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Resolution Therapeutics Patents

Resolution Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202411901-D0 Method of producing macrophages Inactive 13-Aug-2024
GB-202404277-D0 Method of producing macrophages Inactive 26-Mar-2024
WO-2025202287-A1 Method of producing macrophages Pending 26-Mar-2024
AU-2024352437-A1 Therapeutic macrophages Pending 27-Sep-2023
EP-4784730-A1 Therapeutic macrophages Pending 27-Sep-2023 C12N5/0645
To view Resolution Therapeutics’s complete patent history, request access »

Resolution Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Resolution Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Old College Capital Venture Capital Minority
Syncona Venture Capital Minority
The University of Edinburgh University
To view Resolution Therapeutics’s complete investors history, request access »

Resolution Therapeutics FAQs

  • When was Resolution Therapeutics founded?

    Resolution Therapeutics was founded in 2017.

  • Where is Resolution Therapeutics headquartered?

    Resolution Therapeutics is headquartered in London, United Kingdom.

  • What is the size of Resolution Therapeutics?

    Resolution Therapeutics has 55 total employees.

  • What industry is Resolution Therapeutics in?

    Resolution Therapeutics’s primary industry is Drug Discovery.

  • Is Resolution Therapeutics a private or public company?

    Resolution Therapeutics is a Private company.

  • What is Resolution Therapeutics’s current revenue?

    The current revenue for Resolution Therapeutics is .

  • How much funding has Resolution Therapeutics raised over time?

    Resolution Therapeutics has raised $119M.

  • Who are Resolution Therapeutics’s investors?

    Old College Capital, Syncona, and The University of Edinburgh have invested in Resolution Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process